286 related articles for article (PubMed ID: 22479405)
1. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
Zhou X; Evans SL; Han X; Liu Y; Yu XF
PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
[TBL] [Abstract][Full Text] [Related]
2. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
3. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
[TBL] [Abstract][Full Text] [Related]
4. Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.
Wang X; Wang X; Zhang H; Lv M; Zuo T; Wu H; Wang J; Liu D; Wang C; Zhang J; Li X; Wu J; Yu B; Kong W; Yu X
Retrovirology; 2013 Aug; 10():94. PubMed ID: 23988114
[TBL] [Abstract][Full Text] [Related]
5. Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex.
Salter JD; Lippa GM; Belashov IA; Wedekind JE
Biochemistry; 2012 Nov; 51(44):8702-4. PubMed ID: 23098073
[TBL] [Abstract][Full Text] [Related]
6. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.
Guo Y; Dong L; Qiu X; Wang Y; Zhang B; Liu H; Yu Y; Zang Y; Yang M; Huang Z
Nature; 2014 Jan; 505(7482):229-33. PubMed ID: 24402281
[TBL] [Abstract][Full Text] [Related]
8. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.
Zhou X; Han X; Zhao K; Du J; Evans SL; Wang H; Li P; Zheng W; Rui Y; Kang J; Yu XF
J Virol; 2014 Mar; 88(5):2555-63. PubMed ID: 24352440
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.
Kobayashi M; Takaori-Kondo A; Miyauchi Y; Iwai K; Uchiyama T
J Biol Chem; 2005 May; 280(19):18573-8. PubMed ID: 15781449
[TBL] [Abstract][Full Text] [Related]
10. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.
Miyagi E; Welbourn S; Sukegawa S; Fabryova H; Kao S; Strebel K
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941780
[TBL] [Abstract][Full Text] [Related]
13. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
[TBL] [Abstract][Full Text] [Related]
14. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.
Bergeron JR; Huthoff H; Veselkov DA; Beavil RL; Simpson PJ; Matthews SJ; Malim MH; Sanderson MR
PLoS Pathog; 2010 Jun; 6(6):e1000925. PubMed ID: 20532212
[TBL] [Abstract][Full Text] [Related]
15. Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.
Matsui Y; Shindo K; Nagata K; Io K; Tada K; Iwai F; Kobayashi M; Kadowaki N; Harris RS; Takaori-Kondo A
Virology; 2014 Jan; 449():82-7. PubMed ID: 24418540
[TBL] [Abstract][Full Text] [Related]
16. Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase.
Wang H; Lv G; Zhou X; Li Z; Liu X; Yu XF; Zhang W
BMC Microbiol; 2014 Nov; 14():290. PubMed ID: 25424878
[TBL] [Abstract][Full Text] [Related]
17. Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction.
Lu Z; Bergeron JR; Atkinson RA; Schaller T; Veselkov DA; Oregioni A; Yang Y; Matthews SJ; Malim MH; Sanderson MR
Open Biol; 2013 Nov; 3(11):130100. PubMed ID: 24225024
[TBL] [Abstract][Full Text] [Related]
18. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
[TBL] [Abstract][Full Text] [Related]
19. Dissection of the HIV Vif interaction with human E3 ubiquitin ligase.
Wolfe LS; Stanley BJ; Liu C; Eliason WK; Xiong Y
J Virol; 2010 Jul; 84(14):7135-9. PubMed ID: 20463065
[TBL] [Abstract][Full Text] [Related]
20. CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
Kim DY; Kwon E; Hartley PD; Crosby DC; Mann S; Krogan NJ; Gross JD
Mol Cell; 2013 Feb; 49(4):632-44. PubMed ID: 23333304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]